SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Apricus Biosciences
An SI Board Since September 2014
Posts SubjectMarks Bans Symbol
2026 18 0 APRI
Emcee:  mokelumne river Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1826the carcinogenic study is no longer an issue, was resolved long time ago, the laeico20-4/6/2016
1825Apricus Biosciences, Inc updated its strategic objectives today to include its phollyhunter-4/6/2016
1824Eman can confirm I believe ... The carcinogenic study Is a moot point as the FDapriluv-4/6/2016
1823I would love to see Sarissa appoint someone to the board. I would really like tphoenix_rising-4/6/2016
1822The FDA asked for certain studies to be performed- the last time that they had cMirror Image-4/6/2016
1821I'm quite concerned based on their track record for fcking things up that thphoenix_rising-4/6/2016
1820Yep. That means it is back to Allergan making the decision as to whether to marmokelumne river-4/6/2016
1819Pfizer deal is dead wsj.comphoenix_rising-4/6/2016
1818I know, I know. I could easily see Pfizer dragging its feet, which would be wormokelumne river-4/5/2016
1817If we knew that for SURE Pfizer would aggressively market Vitaros if/when approvMirror Image-4/5/2016
1816Late breaking news this morning: Allergan ( AGN) – Shares are under pressure afmokelumne river-4/5/2016
1815James thank you for your response. I suppose the mention of Vitaros US approval Strong Long-4/2/2016
1814HellSails - If you see this message - Could you confirm if they are currently stMirror Image-4/2/2016
1813As far as I know - Sarissa - is allowed to appoint one person to the Board of DiMirror Image-4/2/2016
1812Does anyone have insight about Denner/Sarissa? Will they become active in managiOldBoar-4/1/2016
1811SL, by 2017 we will know if the FDA approves or not. If it approves and Pfizer mokelumne river-4/1/2016
1810I keep replaying Pascoes recent webcast addressing the Fis results and the compaStrong Long-4/1/2016
1809Another point to consider is that they need to do some more refinancing to suppophoenix_rising-3/30/2016
1808Eman, you and SL bear witness to the editing that I do after a few hours of thinmokelumne river-3/30/2016
1807good points James, Pascoe said he has 3 other partners waiting if Allergan opts eico20-3/30/2016
1806James great points here and on the other board. While there are those on the othStrong Long-3/30/2016
1805Eman, once upon a time we would have thought that US approval and marketing woulmokelumne river-3/30/2016
1804I agree James, US approval is crucial now, I'm willing to bet that they do heico20-3/30/2016
1803Yep, you are right. We will see in a few months.mokelumne river-3/30/2016
1802I'm not convinced they can get FDA approval without more trials. I think itphoenix_rising-3/30/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News